JP2024518379A5 - - Google Patents
Info
- Publication number
- JP2024518379A5 JP2024518379A5 JP2023567911A JP2023567911A JP2024518379A5 JP 2024518379 A5 JP2024518379 A5 JP 2024518379A5 JP 2023567911 A JP2023567911 A JP 2023567911A JP 2023567911 A JP2023567911 A JP 2023567911A JP 2024518379 A5 JP2024518379 A5 JP 2024518379A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- lipid
- lipid conjugate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184568P | 2021-05-05 | 2021-05-05 | |
| US63/184,568 | 2021-05-05 | ||
| PCT/US2022/027857 WO2022235923A2 (en) | 2021-05-05 | 2022-05-05 | Peptide-lipid conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518379A JP2024518379A (ja) | 2024-05-01 |
| JP2024518379A5 true JP2024518379A5 (https=) | 2025-05-12 |
Family
ID=83932474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567911A Pending JP2024518379A (ja) | 2021-05-05 | 2022-05-05 | ペプチド－脂質コンジュゲート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220378702A1 (https=) |
| EP (1) | EP4333898A4 (https=) |
| JP (1) | JP2024518379A (https=) |
| CN (1) | CN118201639A (https=) |
| AU (1) | AU2022271263A1 (https=) |
| CA (1) | CA3219056A1 (https=) |
| WO (1) | WO2022235923A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119874799A (zh) * | 2023-01-18 | 2025-04-25 | 仁景(苏州)生物科技有限公司 | 脂质化合物和脂质纳米颗粒组合物 |
| WO2025166325A1 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010530433A (ja) * | 2007-06-20 | 2010-09-09 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｐｏａ−１ペプチド模倣体 |
| WO2009092396A1 (en) * | 2008-01-25 | 2009-07-30 | Universitätsklinikum Heidelberg | Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| US8268796B2 (en) * | 2008-06-27 | 2012-09-18 | Children's Hospital & Research Center At Oakland | Lipophilic nucleic acid delivery vehicle and methods of use thereof |
| CN103097413A (zh) * | 2010-07-09 | 2013-05-08 | Jv生物公司 | 脂质缀合抗体 |
| ES2663368T3 (es) * | 2011-02-10 | 2018-04-12 | Ruprecht-Karls-Universität Heidelberg | Péptidos modificados hidrófobos y uso de los mismos para su direccionamiento específico al hígado |
| KR102455171B1 (ko) * | 2013-12-18 | 2022-10-14 | 더 스크립스 리서치 인스티튜트 | 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물 |
| WO2019191780A1 (en) * | 2018-03-30 | 2019-10-03 | Arcturus Therapeutics, Inc. | Lipid particles for nucleic acid delivery |
| EP3856757A4 (en) * | 2018-09-28 | 2022-06-29 | Nutcracker Therapeutics, Inc. | Tertiary amino lipidated cationic peptides for nucleic acid delivery |
| CA3219053A1 (en) * | 2021-05-05 | 2022-11-10 | Arcturus Therapeutics, Inc. | Lipid compositions comprising peptide-lipid conjugates |
-
2022
- 2022-05-05 US US17/737,862 patent/US20220378702A1/en active Pending
- 2022-05-05 EP EP22799589.1A patent/EP4333898A4/en active Pending
- 2022-05-05 AU AU2022271263A patent/AU2022271263A1/en active Pending
- 2022-05-05 CA CA3219056A patent/CA3219056A1/en active Pending
- 2022-05-05 JP JP2023567911A patent/JP2024518379A/ja active Pending
- 2022-05-05 WO PCT/US2022/027857 patent/WO2022235923A2/en not_active Ceased
- 2022-05-05 CN CN202280044059.3A patent/CN118201639A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024518379A5 (https=) | ||
| JP7641308B2 (ja) | Ｒｎａ送達のためのイオン化可能なカチオン性脂質 | |
| Niculescu-Duvaz et al. | Structure-activity relationship in cationic lipid mediated gene transfection | |
| JP2023538260A5 (https=) | ||
| JP7741872B2 (ja) | 化合物またはその塩、脂質粒子および医薬組成物 | |
| JP2005526727A5 (https=) | ||
| KR970704889A (ko) | 핵산-함유 조성물, 이의 제조 방법 및 용도 | |
| CN107207428A (zh) | 用于rna递送的可电离阳离子脂质 | |
| JP2005517739A5 (https=) | ||
| CN118251497A (zh) | 包括肽-脂质缀合物的脂质组合物 | |
| CN119522092A (zh) | 用于核酸递送的基于多价分子的脂质纳米颗粒 | |
| KR20220045204A (ko) | 핵산 전달을 위한 지질화된 양이온성 펩타이드-peg 조성물 | |
| CN118201639A (zh) | 肽-脂质缀合物 | |
| JP2024512770A (ja) | 遺伝子送達における非ウイルスベクターとしての樹状構造 | |
| JP2004515228A (ja) | 細胞への導入を容易にするジェミニ型のペプチド系界面活性化合物 | |
| JP2001515060A (ja) | 新リポポリアミン、その調製および適用 | |
| WO2024017254A1 (zh) | 氨基脂质化合物、其制备方法和应用 | |
| EP4480943A1 (en) | New class of lipids for delivering active ingredients into cells | |
| WO2025172284A1 (en) | Lipids for nanoparticle delivery platform | |
| WO2026052114A1 (zh) | 脂质纳米颗粒及其应用 |